Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years
Clinical trial NCT02434276 · UNKNOWN
Trial details
- NCT number
- NCT02434276
- Sponsor
- VaxInnate Corporation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-08-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.